Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App




More Accurate Use of Antibiotics Could Save the NHS GBP 500 Million Annually

By LabMedica International staff writers
Posted on 19 Aug 2014
The UK National Health Service (NHS; UK) could save an estimated GBP 500 million each year while reducing the threat of antibiotic resistance by managing the use of antibiotics with more accurate diagnostics. More...


Against a backdrop of growing global concern, the UK has responded with a major initiative to tackle antimicrobial resistance, with the establishment of a cabinet aimed at combining the minds and efforts of leading research bodies to achieve a collective response. As new research from Public Health England and University College London revealed that the proportion of UK patients given antibiotics for coughs and colds has risen by a staggering 40% since 2000, the debate around the issue assumes additional urgency.

“This study further validates our concerns and reinforces the pressing need for real action," said Dr. Peter FitzGerald, Managing Director at Randox, "There are solutions – new technology to improve diagnostics is available. We are calling on the newly established ‘war cabinet on antimicrobial resistance’ to engage this technology as part of their weaponry and start tackling the issue at the frontline.” As the search for answers continues, Dr. FitzGerald recommends that the cabinet and the medical community make a rapid appraisal of existing innovative technologies with the ability to help.

More accurate diagnosis will improve patient care, reduce unnecessary prescribing, and reduce cost. An estimated 1 million people each year across the UK spend at least 1 week in hospital due to respiratory infections. Using basic calculations, scientists at Randox Laboratories Ltd. (Crumlin, Northern Ireland) estimated that through reducing the average length of hospital stay from 7 to 5 days for patients admitted with respiratory infections, the NHS could save GBP 500 million each year.

Early, first-time diagnosis is critical and scientists at Randox have revealed their latest weapon in the fight against antibiotic resistance: a new test for the identification of respiratory infections—the Randox Respiratory Array. The test screens patient saliva, mucus, or sputum and can accurately identify up to 22 infections, both viral and bacterial, simultaneously, with results to the physician on the same day. The test will contribute to much needed progress, enabling doctors to prescribe the correct antibiotic (not just "an" antibiotic), or another form of effective medication.

"By utilizing our existing resources and employing pioneering technology to inform diagnosis, we can facilitate a much needed behavioral change in prescribing habits," said Dr. FitzGerald. With advanced diagnostic tests such as the Randox Respiratory Array, many infections can be diagnosed accurately within the same day, empowering doctors to prescribe appropriate treatment at first presentation, rather than a "one size fits all" tendency in the current overprescribing of antibiotics.

Related Links:

Randox
National Health Service



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.